273 related articles for article (PubMed ID: 22889367)
21. High prevalence of Pfdhfr-Pfdhps quadruple mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea.
Jiang T; Chen J; Fu H; Wu K; Yao Y; Eyi JUM; Matesa RA; Obono MMO; Du W; Tan H; Lin M; Li J
Malar J; 2019 Mar; 18(1):101. PubMed ID: 30914041
[TBL] [Abstract][Full Text] [Related]
22. Increased prevalence of pfdhfr and pfdhps mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Jazan Region, Southwestern Saudi Arabia: important implications for malaria treatment policy.
Madkhali AM; Al-Mekhlafi HM; Atroosh WM; Ghzwani AH; Zain KA; Abdulhaq AA; Ghailan KY; Anwar AA; Eisa ZM
Malar J; 2020 Dec; 19(1):446. PubMed ID: 33267841
[TBL] [Abstract][Full Text] [Related]
23. A molecular epidemiologic study of point mutations for pyrimethamine-sulfadoxine resistance of Plasmodium falciparum isolates from Lao PDR.
Toma H; Imada Y; Vannachone B; Miyagi M; Kobayashi J; Uechi G; Pethuvang R; Manivong K; Phompida S; Sato Y
Southeast Asian J Trop Med Public Health; 2005 May; 36(3):602-4. PubMed ID: 16124424
[TBL] [Abstract][Full Text] [Related]
24. Ordered accumulation of mutations conferring resistance to sulfadoxine-pyrimethamine in the Plasmodium falciparum parasite.
Mita T; Ohashi J; Venkatesan M; Marma AS; Nakamura M; Plowe CV; Tanabe K
J Infect Dis; 2014 Jan; 209(1):130-9. PubMed ID: 23922363
[TBL] [Abstract][Full Text] [Related]
25. Plasmodium falciparum isolates in India exhibit a progressive increase in mutations associated with sulfadoxine-pyrimethamine resistance.
Ahmed A; Bararia D; Vinayak S; Yameen M; Biswas S; Dev V; Kumar A; Ansari MA; Sharma YD
Antimicrob Agents Chemother; 2004 Mar; 48(3):879-89. PubMed ID: 14982779
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms in Plasmodium falciparum dihydropteroate synthetase and dihydrofolate reductase genes in Nigerian children with uncomplicated malaria using high-resolution melting technique.
Kayode AT; Ajogbasile FV; Akano K; Uwanibe JN; Oluniyi PE; Eromon PJ; Folarin OA; Sowunmi A; Wirth DF; Happi CT
Sci Rep; 2021 Jan; 11(1):471. PubMed ID: 33436791
[TBL] [Abstract][Full Text] [Related]
27. Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins.
Wang P; Lee CS; Bayoumi R; Djimde A; Doumbo O; Swedberg G; Dao LD; Mshinda H; Tanner M; Watkins WM; Sims PF; Hyde JE
Mol Biochem Parasitol; 1997 Nov; 89(2):161-77. PubMed ID: 9364963
[TBL] [Abstract][Full Text] [Related]
28. Differences in selective pressure on dhps and dhfr drug resistant mutations in western Kenya.
McCollum AM; Schneider KA; Griffing SM; Zhou Z; Kariuki S; Ter-Kuile F; Shi YP; Slutsker L; Lal AA; Udhayakumar V; Escalante AA
Malar J; 2012 Mar; 11():77. PubMed ID: 22439637
[TBL] [Abstract][Full Text] [Related]
29. Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania.
Pearce RJ; Drakeley C; Chandramohan D; Mosha F; Roper C
Antimicrob Agents Chemother; 2003 Apr; 47(4):1347-54. PubMed ID: 12654669
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
Happi CT; Gbotosho GO; Folarin OA; Akinboye DO; Yusuf BO; Ebong OO; Sowunmi A; Kyle DE; Milhous W; Wirth DF; Oduola AM
Acta Trop; 2005 Sep; 95(3):183-93. PubMed ID: 16023986
[TBL] [Abstract][Full Text] [Related]
31. DHFR and DHPS genotypes of Plasmodium falciparum isolates from Gabon correlate with in vitro activity of pyrimethamine and cycloguanil, but not with sulfadoxine-pyrimethamine treatment efficacy.
Aubouy A; Jafari S; Huart V; Migot-Nabias F; Mayombo J; Durand R; Bakary M; Le Bras J; Deloron P
J Antimicrob Chemother; 2003 Jul; 52(1):43-9. PubMed ID: 12805261
[TBL] [Abstract][Full Text] [Related]
32. Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in Uganda: correlation with polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes.
Jelinek T; Kilian AH; Kabagambe G; von Sonnenburg F
Am J Trop Med Hyg; 1999 Sep; 61(3):463-6. PubMed ID: 10497991
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum isolates from southern Mauritania.
Eberl KJ; Jelinek T; Aida AO; Peyerl-Hoffmann G; Heuschkel C; el Valy AO; Christophel EM
Trop Med Int Health; 2001 Oct; 6(10):756-60. PubMed ID: 11679122
[TBL] [Abstract][Full Text] [Related]
34. Geographical spread and structural basis of sulfadoxine-pyrimethamine drug-resistant malaria parasites.
Chaturvedi R; Chhibber-Goel J; Verma I; Gopinathan S; Parvez S; Sharma A
Int J Parasitol; 2021 Jun; 51(7):505-525. PubMed ID: 33775670
[TBL] [Abstract][Full Text] [Related]
35. Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum and resistance to sulfadoxine-pyrimethamine in Sri Lanka.
Hapuarachchi HC; Dayanath MY; Bandara KB; Abeysundara S; Abeyewickreme W; de Silva NR; Hunt SY; Sibley CH
Am J Trop Med Hyg; 2006 Feb; 74(2):198-204. PubMed ID: 16474070
[TBL] [Abstract][Full Text] [Related]
36. Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization.
Wang P; Read M; Sims PF; Hyde JE
Mol Microbiol; 1997 Mar; 23(5):979-86. PubMed ID: 9076734
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum isolates from India and Thailand: a molecular epidemiologic study.
Biswas S; Escalante A; Chaiyaroj S; Angkasekwinai P; Lal AA
Trop Med Int Health; 2000 Oct; 5(10):737-43. PubMed ID: 11044269
[TBL] [Abstract][Full Text] [Related]
38. Point mutations in dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum isolates from Venezuela.
Urdaneta L; Plowe C; Goldman I; Lal AA
Am J Trop Med Hyg; 1999 Sep; 61(3):457-62. PubMed ID: 10497990
[TBL] [Abstract][Full Text] [Related]
39. Plasmodium falciparum drug resistance-associated mutations in isolates from children living in endemic areas of Burkina Faso.
Tarama CW; Soré H; Siribié M; Débé S; Kinda R; Ganou A; Nonkani WG; Tiendrebeogo F; Bantango W; Yira K; Sagnon A; Ilboudo S; Hien EY; Guelbéogo MW; Sagnon N; Traoré Y; Ménard D; Gansané A
Malar J; 2023 Jul; 22(1):213. PubMed ID: 37474966
[TBL] [Abstract][Full Text] [Related]
40. Common origin and fixation of Plasmodium falciparum dhfr and dhps mutations associated with sulfadoxine-pyrimethamine resistance in a low-transmission area in South America.
McCollum AM; Mueller K; Villegas L; Udhayakumar V; Escalante AA
Antimicrob Agents Chemother; 2007 Jun; 51(6):2085-91. PubMed ID: 17283199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
